Biotech Acquisition Co (Biotech Acquisition Co) Ending Cash Position : $0.01 Mil (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Biotech Acquisition Co Ending Cash Position?

Biotech Acquisition Co's Ending Cash Position for the quarter that ended in Sep. 2022 was $0.01 Mil.

Biotech Acquisition Co's quarterly Ending Cash Position declined from Mar. 2022 ($0.10 Mil) to Jun. 2022 ($0.00 Mil) but then increased from Jun. 2022 ($0.00 Mil) to Sep. 2022 ($0.01 Mil).

Biotech Acquisition Co's annual Ending Cash Position stayed the same from . 20 ($0.00 Mil) to Dec. 2020 ($0.00 Mil) but then increased from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($0.09 Mil).

Biotech Acquisition Co Ending Cash Position Historical Data

The historical data trend for Biotech Acquisition Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Acquisition Co Ending Cash Position Chart

Biotech Acquisition Co Annual Data

Trend

Dec20

Dec21

Ending Cash Position

0.09

Biotech Acquisition Co Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Ending Cash Position	Get a 7-Day Free Trial				0.40	0.09	0.10	-	0.01

Biotech Acquisition Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Biotech Acquisition Co's Ending Cash Position for the fiscal year that ended in Dec. 2021 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	-0.00099999999998787	+	0.091999999999988
	=	0.09

Biotech Acquisition Co's Ending Cash Position for the quarter that ended in Sep. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.002	+	0.011
	=	0.01

Biotech Acquisition Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Biotech Acquisition Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotech Acquisition Co (Biotech Acquisition Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Biotech Acquisition Co (NAS:BIOT) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

545 West 25th Street, 20th Floor, New York, NY, USA, 10001

Website

Biotech Acquisition Co is a blank check company.

Executives

Albert F Hummel	director, officer: Chief Investment Officer	PO BOX 3407, RANCHO SANTA FE CA 92067
Biotech Sponsor Llc	10 percent owner	545 W. 25TH ST., 20TH FLOOR, NEW YORK NY 10001
Bruno Montanari	director	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Ivan Jarry	officer: Chief Operating Officer	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Paul Bernard	director	545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Aaron Kim	director	545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Michael Schleifer	director, 10 percent owner, officer: Chief Executive Officer	545 WEST 25TH STREET 20TH FLOOR, NEW YORK NY 10001
Thomas Fratacci	officer: CFO & Treasurer	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001